SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028944
Filing Date
2018-11-09
Accepted
2018-11-09 16:31:25
Documents
49
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zfgn-10q_20180930.htm 10-Q 1862968
2 EX-31.1 zfgn-ex311_6.htm EX-31.1 7985
3 EX-31.2 zfgn-ex312_8.htm EX-31.2 7989
4 EX-32.1 zfgn-ex321_7.htm EX-32.1 13110
  Complete submission text file 0001564590-18-028944.txt   5379846

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT zfgn-20180930.xml EX-101.INS 1134460
6 XBRL TAXONOMY EXTENSION SCHEMA zfgn-20180930.xsd EX-101.SCH 32149
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zfgn-20180930_cal.xml EX-101.CAL 38739
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zfgn-20180930_def.xml EX-101.DEF 87548
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE zfgn-20180930_lab.xml EX-101.LAB 246890
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zfgn-20180930_pre.xml EX-101.PRE 179763
Mailing Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114
Business Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114 617-622-4003
ZAFGEN, INC. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36510 | Film No.: 181173505
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1